Sandu Pharmaceuticals standalone net profit rises 29.41% in the June 2025 quarter
Sales decline 2.05% to Rs 16.70 crore
Net profit of Sandu Pharmaceuticals rose 29.41% to Rs 0.22 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales declined 2.05% to Rs 16.70 crore in the quarter ended June 2025 as against Rs 17.05 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales16.7017.05 -2 OPM %3.172.46 -PBDT0.520.44 18 PBT0.340.28 21 NP0.220.17 29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 14 2025 | 7:35 AM IST